Cite

HARVARD Citation

    Li, S. et al. (2022). Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Journal of clinical oncology. 40 (14), pp. 1529-1541. [Online]. 
  
Back to record